XML 41 R21.htm IDEA: XBRL DOCUMENT v3.21.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Basic and diluted net loss per share
    December 31,  
    2020     2019  
Numerator for basic and diluted net loss per share:            
Net loss attributable to Sanara MedTech common shareholders   $ (4,356,440 )   $ (2,814,088 )
Denominator for basic and diluted net loss per share:                
Weighted average shares used to compute diluted net loss per share     5,734,537       2,132,745  
                 
Basic and diluted net loss per share attributable to common shareholders   $ (0.76 )   $ (1.32 )
Anti-dilutive securities
    As of December 31,  
    2020     2019  
             
Stock options     11,500       11,500  
Convertible debt     -       178,173  
Preferred shares     -       2,273,630  
Unvested restricted stock       170,178        -  
Disaggregation of revenue
    Year Ended  
    December 31,  
    2020     2019  
Product sales revenue   $ 15,385,976     $ 11,607,638  
Royalty revenue     201,000       159,125  
Total Revenue   $ 15,586,976     $ 11,766,763  
Property and equipment
    December 31,     December 31,  
    2020     2019  
Computers   $ 87,252     $ 87,310  
Office equipment     22,597       22,312  
Furniture and fixtures     205,871       153,995  
Leasehold improvements     2,030       2,030  
Capitalized software development costs     485,530       -  
      803,280       265,647  
Less accumulated depreciation     (124,691 )     (60,694 )
                 
Property and equipment, net   $ 678,589     $ 204,953